Novel targets for platelet inhibition

Handbook of Experimental Pharmacology

Volumn 210, Issue , 2012, Pages 369-394

  Freson, Kathleen ^a   Van Geet, Chris ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Antiplatelet drugs; Functional genomics; Genome wide association studies; Inherited bleeding disorder; Proteomics

Indexed keywords

ACTIN BINDING PROTEIN; ALDEHYDE REDUCTASE; CD39 ANTIGEN; ECTO NUCLEOTIDASE; FIBRINOGEN RECEPTOR; GLYCOPROTEIN VI; GREEN FLUORESCENT PROTEIN; GROWTH ARREST SPECIFIC PROTEIN 6; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; IMMUNOGLOBULIN RECEPTOR; IMMUNOGLOBULIN RECEPTOR G6B; LEPTIN; LEPTIN RECEPTOR; NUCLEOTIDASE; PROTEIN DISULFIDE ISOMERASE; PROTEIN ERP57; PROTEIN GS ALPHA; PROTEIN HIP 55; RGS2 PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBOCYTE RECEPTOR; TYROSINE KINASE RECEPTOR; TYROSINE KINASE RECEPTOR 3; TYROSINE KINASE RECEPTOR AXL; TYROSINE KINASE RECEPTOR MER; UNCLASSIFIED DRUG; ANTITHROMBOCYTIC AGENT; CYCLIC AMP;

ARTICLE; DIAGNOSTIC TEST; FUNCTIONAL GENOMICS; FUNCTIONAL PLATELET TESTING; GENETIC ASSOCIATION; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEOMICS; THROMBOCYTE DISORDER; THROMBOCYTE FUNCTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; GENOMICS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC AMP; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; PLATELET AGGREGATION INHIBITORS; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84867168448     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-29423-5_15     Document Type: Article

References (85)

1. Adam F, Kauskot A, Nurden P, Sulpice E, Hoylaerts MF, Davis RJ, Rosa JP, Bryckaert M (2010) Platelet JNK1 is involved in secretion and thrombus formation. Blood 115:4083-4092
2. Akbar H, Kim J, Funk K, Cancelas JA, Shang X, Chen L, Johnson JF, Williams DA, Zheng Y (2007) Genetic and pharmacologic evidence that Rac1 GTPase is involved in regulation of platelet secretion and aggregation. J Thromb Haemost 5:1747-1755
3. Angelillo-Scherrer A, de Frutos P, Aparicio C, Melis E, Savi P, Lupu F, Arnout J, Dewerchin M, Hoylaerts M, Herbert J, Collen D, Dahlbäck B, Carmeliet P (2001) Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 7:215-221
4. Angelillo-Scherrer A, Burnier L, Flores N, Savi P, DeMol M, Schaeffer P, Herbert JM, Lemke G, Goff SP, Matsushima GK, Earp HS, Vesin C, Hoylaerts MF, Plaisance S, Collen D, Conway EM, Wehrle-Haller B, Carmeliet P (2005) Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest 115:237-246
5. Banks WA, Kastin AJ, Komaki G, Arimura A (1993) Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier. J Pharmacol Exp Ther 267:690-696
6. Bennett JS, Mousa S (2001) Platelet function inhibitors in the year 2000. Thromb Haemost 85:395-400
7. Bennett JS (2001) Novel platelet inhibitors. Annu Rev Med 52:161-184
8. Bergmeier W, Goerge T, Wang HW, Crittenden JR, Baldwin AC, Cifuni SM, Housman DE, Graybiel AM, Wagner DD (2007) Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III. J Clin Invest 117:1699-1707
9. Chen J, De S, Damron DS, Chen WS, Hay N, Byzova TV (2004) Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 104:1703-1710
10. Chrzanowska-Wodnicka M, Smyth SS, Schoenwaelder SM, Fischer TH, White GC 2nd (2005) Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest 115:680-687
11. Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, Maguire PB (2004) Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103:2096-2104
12. Cosemans JM, Van Kruchten R, Olieslagers S, Schurgers LJ, Verheyen FK, Munnix IC, Waltenberger J, Angelillo-Scherrer A, Hoylaerts MF, Carmeliet P, Heemskerk JW (2010) Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization. J Thromb Haemost 8:1797-1808
13. Dellas C, Schäfer K, Rohm IK, Lankeit M, Leifheit M, Loskutoff DJ, Hasenfuss G, Konstantinides SV (2007) Leptin signalling and leptin-mediated activation of human platelets: importance of JAK2 and the phospholipases Cgamma2 and A2. Thromb Haemost 98(106):3-71
14. Di Michele M, Thys C, Waelkens E, Overbergh L, D'Hertog W, Mathieu C, De Vos R, Peerlinck K, Van Geet C, Freson K (2011) An integrated proteomics and genomics analysis to unravel a heterogeneous platelet secretion defect. J Proteomics 74:902-913
15. Dwyer KM, Robson SC, Nandurkar HH, Campbell DJ, Gock H, Murray-Segal LJ, Fisicaro N, Mysore TB, Kaczmarek E, Cowan PJ, d'Apice AJ (2004) Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 113:1440-1446
16. Enjyoji K, Sévigny J, Lin Y, Frenette PS, Christie PD, Esch JS 2nd, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD (1999) Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010-1017
17. Foy M, Maguire PB (2007) Recent advances in the characterisation of the platelet membrane system by proteomics. Curr Pharm Des 13:2647-2655
18. Freson K, Hoylaerts MF, Jaeken J, Eyssen M, Arnout J, Vermylen J, Van Geet C (2001) Genetic variation of the extra-large stimulatory G protein alpha-subunit leads to Gs hyperfunction in platelets and is a risk factor for bleeding. Thromb Haemost 86:733-738
19. Freson K, Jaeken J, Van Helvoirt M, de Zegher F, Wittevrongel C, Thys C, Hoylaerts MF, Vermylen J, Van Geet C (2003) Functional polymorphisms in the paternally expressed XLalphas and its cofactor ALEX decrease their mutual interaction and enhance receptormediated cAMP formation. Hum Mol Genet 12:1121-1130
20. Freson K, Hashimoto H, Thys C, Wittevrongel C, Danloy S, Morita Y, Shintani N, Tomiyama Y, Vermylen J, Hoylaerts MF, Baba A, Van Geet C (2004) The pituitary adenylate cyclaseactivating polypeptide is a physiological inhibitor of platelet activation. J Clin Invest 113:905-912
21. Freson K, Izzi B, Jaeken J, Van Helvoirt M, Thys C, Wittevrongel C, de Zegher F, Van Geet C (2008) Compound heterozygous mutations in the GNAS gene of a boy with morbid obesity, thyroid-stimulating hormone resistance, pseudohypoparathyroidism, and a prothrombotic state. J Clin Endocrinol Metab 93:4844-4849
22. Garcia BA, Smalley DM, Cho H et al (2005) The platelet microparticle proteome. J Proteome Res 4:1516-1521
23. Goodall AH, Burns P, Salles I, Macaulay IC, Jones CI, Ardissino D, de Bono B, Bray SL, Deckmyn H, Dudbridge F, Fitzgerald DJ, Garner SF, Gusnanto A, Koch K, Langford C, O'Connor MN, Rice CM, Stemple D, Stephens J, Trip MD, Zwaginga JJ, Samani NJ, Watkins NA, Maguire PB, Ouwehand WH, Bloodomics Consortium (2010) Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function. Blood 116:4646-4656
24. Goschnick MW, Lau LM, Wee JL, Liu YS, Hogarth PM, Robb LM, Hickey MJ, Wright MD, Jackson DE (2006) Impaired "outside-in" integrin alphaIIbbeta3 signaling and thrombus stability in TSSC6-deficient mice. Blood 108:1911-1918
25. Graham GJ, Ren Q, Dilks JR, Blair P, Whiteheart SW, Flaumenhaft R (2009) Endobrevin/VAMP- 8-dependent dense granule release mediates thrombus formation in vivo. Blood 114:1083-1090
26. Han J, Kori R, Shui JW, Chen YR, Yao Z, Tan TH (2003) The SH3 domain-containing adaptor HIP-55 mediates c-Jun N-terminal kinase activation in T cell receptor signaling. J Biol Chem 278:52195-52202
27. Harper MT, Poole AW (2010) Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. J Thromb Haemost 8:454-462
28. Hernandez-Ruiz L, Valverde F, Jimenez-Nunez MD, Ocana E, Sáez-Benito A, Rodríguez- Martorell J, Bohórquez JC, Serrano A, Ruiz FA (2007) Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J Proteome Res 6:4449-4457
29. Herrera-Galeano JE, Becker DM, Wilson AF, Yanek LR, Bray P, Vaidya D, Faraday N, Becker LC (2008) A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability. Arterioscler Thromb Vasc Biol 28:1484-1490
30. Hirsch E, Bosco O, Tropel P, Laffargue M, Calvez R, Altruda F, Wymann M, Montrucchio G (2001) Resistance to thromboembolism in PI3Kgamma-deficient mice. FASEB J 15:2019-2021
31. Jackson SP, Schoenwaelder SM, Goncalves I, Nesbitt WS, Yap CL, Wright CE, Kenche V, Anderson KE, Dopheide SM, Yuan Y, Sturgeon SA, Prabaharan H, Thompson PE, Smith GD, Shepherd PR, Daniele N, Kulkarni S, Abbott B, Saylik D, Jones C, Lu L, Giuliano S, Hughan SC, Angus JA, Robertson AD, Salem HH (2005) PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 11:507-514
32. Johnson AD, Yanek LR, Chen MH, Faraday N, Larson MG, Tofler G, Lin SJ, Kraja AT, Province MA, Yang Q, Becker DM, O'Donnell CJ, Becker LC (2010) Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 42:608-613
33. Jones CI, Bray S, Garner SF, Stephens J, de Bono B, Angenent WG, Bentley D, Burns P, Coffey A, Deloukas P, Earthrowl M, Farndale RW, Hoylaerts MF, Koch K, Rankin A, Rice CM, Rogers J, Samani NJ, Steward M, Walker A, Watkins NA, Akkerman JW, Dudbridge F, Goodall AH, Ouwehand WH, Bloodomics Consortium (2009) A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood 114:1405-1416
34. Konstantinides S, Schäfer K, Koschnick S, Loskutoff DJ (2001) Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 108:1533-1540
35. Kunert S, Meyer I, Fleischhauer S, Wannack M, Fiedler J, Shivdasani RA, Schulze H (2009) The microtubule modulator RanBP10 plays a critical role in regulation of platelet discoid shape and degranulation. Blood 114:5532-5540
36. Lewandrowski U, Wortelkamp S, Lohrig K, Zahedi RP, Wolters DA, Walter U, Sickmann A (2009) Platelet membrane proteomics: a novel repository for functional research. Blood 114: e10-e19
37. Li W, He M, Zhou H, Bourne JW, Liang P (2006) Mutational data integration in gene-oriented files of the Hermansky-Pudlak Syndrome database. Hum Mutat 27:402-407
38. Lin HF, Traver D, Zhu H, Dooley K, Paw BH, Zon LI, Handin RI (2005) Analysis of thrombocyte development in CD41-GFP transgenic zebrafish. Blood 106:3803-3810
39. Lindemann S, Gawaz M (2007) The active platelet: translation and protein synthesis in an anucleate cell. Semin Thromb Hemost 33:144-150
40. Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M, Burns P, Langford CF, Ellis PD, Dudbridge F, Zwaginga JJ, Watkins NA, van der Schoot CE, Ouwehand WH (2007) Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood 109:3260-3269
41. Marcus K, Immler D, Sternberger J, Meyer HE (2000) Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins. Electrophoresis 21:2622-2636
42. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Pinsky DJ, Sesti C, Levi R (2003) Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther 305:9-16
43. Maurer-Spurej E, Kahr WH, Carter CJ, Pittendreigh C, Cameron M, Cyr TD (2008) The value of proteomics for the diagnosis of a platelet-related bleeding disorder. Platelets 19:342-351
44. Maynard DM, Heijnen HF, Horne MK, White JG, Gahl WA (2007) Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 5:1945-1955
45. Maynard DM, Heijnen HF, Gahl WA, Gunay-Aygun M (2010) The a-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome. J Thromb Haemost 8:1786-1796
46. Meisinger C, Prokisch H, Gieger C, Soranzo N, Mehta D, Rosskopf D, Lichtner P, Klopp N, Stephens J, Watkins NA, Deloukas P, Greinacher A, Koenig W, Nauck M, Rimmbach C, Völzke H, Peters A, Illig T, Ouwehand WH, Meitinger T, Wichmann HE, Döring A (2009) A genome-wide association study identifies three loci associated with mean platelet volume. Am J Hum Genet 84:66-71
47. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-574
48. Moebius J, Zahedi RP, Lewandrowski U, Berger C, Walter U, Sickmann A (2005) The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Proteomics 4:1754-1761
49. Mori J, Pearce AC, Spalton JC, Grygielska B, Eble JA, Tomlinson MG, Senis YA, Watson SP (2008) G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2. J Biol Chem 283:35419-35427
50. Moser M, Bauer M, Schmid S, Ruppert R, Schmidt S, Sixt M, Wang HV, Sperandio M, Fässler R (2009) Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells. Nat Med 15:300-305
51. Naik MU, Nigam A, Manrai P, Millili P, Czymmek K, Sullivan M, Naik UP (2009) CIB1 deficiency results in impaired thrombosis: the potential role of CIB1 in outside-in signaling through integrin alpha IIb beta 3. J Thromb Haemost 7:1906-1914
52. Nanda N, Bao M, Lin H, Clauser K, Komuves L, Quertermous T, Conley PB, Phillips DR, Hart MJ (2005) Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation. J Biol Chem 280:24680-24689
53. Newland SA, Macaulay IC, Floto AR, de Vet EC, Ouwehand WH, Watkins NA, Lyons PA, Campbell DR (2007) The novel inhibitory receptor G6B is expressed on the surface of platelets and attenuates platelet function in vitro. Blood 109:4806-4809
54. Noé L, Di Michele M, Giets E, Thys C, Wittevrongel C, De Vos R, Overbergh L, Waelkens E, Jaeken J, Van Geet C, Freson K (2010a) Platelet Gs hypofunction and abnormal morphology resulting from a heterozygous RGS2 mutation. J Thromb Haemost 8:1594-1603
55. Noé L, Peeters K, Izzi B, Van Geet C, Freson K (2010b) Regulators of platelet cAMP levels: clinical and therapeutic implications. Curr Med Chem 17:2897-2905
56. O'Connor MN, Salles II, Cvejic A, Watkins NA, Walker A, Garner SF, Jones CI, Macaulay IC, Steward M, Zwaginga JJ, Bray SL, Dudbridge F, de Bono B, Goodall AH, Deckmyn H, Stemple DL, Ouwehand WH, Bloodomics Consortium (2009) Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins. Blood 113:4754-4762
57. O'Donnell CJ, Larson MG, Feng D, Sutherland PA, Lindpaintner K, Myers RH, D'Agostino RA, Levy D, Tofler GH, Framingham Heart Study (2001) Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation 103:3051-3056
58. Panzer S, Höcker L, Koren D (2006) Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry. Ann Hematol 85:121-125
59. Parguina AF, Grigorian-Shamajian L, Agra RM, Teijeira-Fernández E, Rosa I, Alonso J, Vinuela- Roldán JE, Seoane A, González-Juanatey JR, García A (2010) Proteins involved in platelet signaling are differentially regulated in acute coronary syndrome: a proteomic study. PLoS One 5:e13404
60. Park SK, Olson TA, Ercal N, Summers M, O'Dorisio MS (1996) Characterization of vasoactive intestinal peptide receptors on human megakaryocytes and platelets. Blood 87:4629-4635
61. Peeters K, Stassen JM, Collen D, Van Geet C, Freson K (2008) Emerging treatments for thrombocytopenia: increasing platelet production. Drug Discov Today 13:798-806
62. Piersma SR, Broxterman HJ, Kapci M, de Haas RR, Hoekman K, Verheul HM, Jiménez CR (2009) Proteomics of the TRAP-induced platelet releasate. J Proteomics 72:91-109
63. Pinsky DJ, Broekman MJ, Peschon JJ, Stocking KL, Fujita T, Ramasamy R, Connolly ES Jr, Huang J, Kiss S, Zhang Y, Choudhri TF, McTaggart RA, Liao H, Drosopoulos JH, Price VL, Marcus AJ, Maliszewski CR (2002) Elucidation of the thromboregulatory role of CD39/ ectoapyrase in the ischemic brain. J Clin Invest 109:1031-1040
64. Pozgajová M, Sachs UJ, Hein L, Nieswandt B (2006) Reduced thrombus stability in mice lacking the alpha2A-adrenergic receptor. Blood 108:510-514
65. Premsler T, Lewandrowski U, Sickmann A, Zahedi RP (2011) Phosphoproteome analysis of the platelet plasma membrane. Methods Mol Biol 728:279-290
66. Qureshi AH, Chaoji V, Maiguel D, Faridi MH, Barth CJ, Salem SM, Singhal M, Stoub D, Krastins B, Ogihara M, Zaki MJ, Gupta V (2009) Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling. PLoS One 4:e7627
67. Reinhardt C, von Brühl ML, Manukyan D, Grahl L, Lorenz M, Altmann B, Dlugai S, Hess S, Konrad I, Orschiedt L, Mackman N, Ruddock L, Massberg S, Engelmann B (2008) Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest 118:1110-1122
68. Sacristan D, Marques M, Zamorano J et al (2008) Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients. Proteomics Clin Appl 2:1300-1312
69. Schäfer K, Halle M, Goeschen C, Dellas C, Pynn M, Loskutoff DJ, Konstantinides S (2004) Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 24:112-117
70. Schulz C, Leuschen NV, Fröhlich T, Lorenz M, Pfeiler S, Gleissner CA, Kremmer E, Kessler M, Khandoga AG, Engelmann B, Ley K, Massberg S, Arnold GJ (2010) Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Blood 115:4102-4110
71. Senis YA, Antrobus R, Severin S, Parguina AF, Rosa I, Zitzmann N, Watson SP, García A (2009a) Proteomic analysis of integrin alphaIIbbeta3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions. J Thromb Haemost 7:1718-1726
72. Senis YA, Tomlinson MG, Ellison S, Mazharian A, Lim J, Zhao Y, Kornerup KN, Auger JM, Thomas SG, Dhanjal T, Kalia N, Zhu JW, Weiss A, Watson SP (2009b) The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis. Blood 113:4942-4954
73. Siller-Matula JM, Krumphuber J, Jilma B (2010) Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases. Br J Pharmacol 159:502-517
74. Soranzo N, Rendon A, Gieger C, Jones CI, Watkins NA, Menzel S, Döring A, Stephens J, Prokisch H, Erber W, Potter SC, Bray SL, Burns P, Jolley J, Falchi M, Kühnel B, Erdmann J, Schunkert H, Samani NJ, Illig T, Garner SF, Rankin A, Meisinger C, Bradley JR, Thein SL, Goodall AH, Spector TD, Deloukas P, Ouwehand WH (2009a) A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function. Blood 113:3831-3837
75. Soranzo N, Spector TD, Mangino M, Kühnel B, Rendon A, Teumer A, Willenborg C, Wright B, Chen L, Li M, Salo P, Voight BF, Burns P, Laskowski RA, Xue Y, Menzel S, Altshuler D, Bradley JR, Bumpstead S, Burnett MS, Devaney J, Döring A, Elosua R, Epstein SE, Erber W, Falchi M, Garner SF, Ghori MJ, Goodall AH, Gwilliam R, Hakonarson HH, Hall AS, Hammond N, Hengstenberg C, Illig T, König IR, Knouff CW, McPherson R, Melander O, Mooser V, Nauck M, Nieminen MS, O'Donnell CJ, Peltonen L, Potter SC, Prokisch H, Rader DJ, Rice CM, Roberts R, Salomaa V, Sambrook J, Schreiber S, Schunkert H, Schwartz SM, Serbanovic-Canic J, Sinisalo J, Siscovick DS, Stark K, Surakka I, Stephens J, Thompson JR, Völker U, Völzke H, Watkins NA, Wells GA, Wichmann HE, Van Heel DA, Tyler-Smith C, Thein SL, Kathiresan S, Perola M, Reilly MP, Stewart AF, Erdmann J, Samani NJ, Meisinger C, Greinacher A, Deloukas P, Ouwehand WH, Gieger C (2009b) A genome-wide metaanalysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 41:1182-1190
76. Springer DL, Miller JH, Spinelli SL, Pasa-Tolic L, Purvine SO, Daly DS, Zangar RC, Jin S, Blumberg N, Francis CW, Taubman MB, Casey AE, Wittlin SD, Phipps RP (2009) Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res 8:2261-2272
77. Tams JW, Johnsen AH, Fahrenkrug J (1999) Identification of pituitary adenylate cyclaseactivating polypeptide1-38-binding factor in human plasma, as ceruloplasmin. Biochem J 341:271-276
78. Tournoij E, Weber GJ, Akkerman JW, de Groot PG, Zon LI, Moll FL, Schulte-Merker S (2010) Mlck1a is expressed in zebrafish thrombocytes and is an essential component of thrombus formation. J Thromb Haemost 8:588-595
79. Tucker KL, Sage T, Stevens JM, Jordan PA, Jones S, Barrett NE, St-Arnaud R, Frampton J, Dedhar S, Gibbins JM (2008) A dual role for integrin-linked kinase in platelets: regulating integrin function and alpha-granule secretion. Blood 112:4523-4531
80. Tucker KL, Kaiser WJ, Bergeron AL, Hu H, Dong JF, Tan TH, Gibbins JM (2009) Proteomic analysis of resting and thrombin-stimulated platelets reveals the translocation and functional relevance of HIP-55 in platelets. Proteomics 9:4340-4354
81. Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H, Galas L, Vaudry H (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283-357
82. Xiang YZ, Kang LY, Gao XM, Shang HC, Zhang JH, Zhang BL (2008) Strategies for antiplatelet targets and agents. Thromb Res 123:35-49
83. Yee DL, Sun CW, Bergeron AL, Dong JF, Bray PF (2005) Aggregometry detects platelet hyperreactivity in healthy individuals. Blood 106:2723-2729
84. Yee DL, Bergeron AL, Sun CW, Dong JF, Bray PF (2006) Platelet hyperreactivity generalizes to multiple forms of stimulation. J Thromb Haemost 4:2043-2050
85. Zahedi RP, Lewandrowski U, Wiesner J, Wortelkamp S, Moebius J, Schütz C, Walter U, Gambaryan S, Sickmann A (2008) Phosphoproteome of resting human platelets. J Proteome Res 7:526-534